FastCheck Automated Rapid AST System

Sepsis Rapid Drug Sensitivity  Overall Solution

There are more than 18 million cases of severe sepsis worldwide each year, and 750000 cases of sepsis in the United States each year, and this number is increasing at a rate of 1.5 to 8.0 per cent per year. Sepsis means a dangerous condition with a high mortality rate. About 14,000 people die from its complications every day in the world, and about 215000 people die in the United States every year. According to foreign epidemiological investigations, the mortality rate of sepsis has exceeded that of myocardial infarction and has become the main cause of death of non-cardiac patients in intensive care units. In recent years, although anti-infection treatment and organ function support technology has made great progress, the mortality rate of sepsis is still as high as 30% ~ 70%. Sepsis treatment costs high, medical resources consumption is huge, seriously affect the quality of human life, has caused great threat to human health.

The rapid targeted drug sensitivity solution for sepsis of microbial mass spectrometry + sepsis rapid targeted drug sensitivity analyzer + bacterial liquid preparation instrument given by TahoBiology can give a drug sensitivity test report within 2 hours. It is revolutionary in the field of sepsis.

FastCheck   Automated Rapid AST System

FastCheck is a microbial drug sensitivity analyzer based on direct counting of microorganisms. The timing scheduling mechanism based on tight timing arrangement of multiple channels enables single-copy detection to be completed in about 10 minutes under the framework of the main AST kit. The overall drug sensitivity test time cost brought by the integrated design of combination of incubation, sampling and testing can be controlled within 2 hours. With the Maldi-TOF microorganism mass spectrometer, the identification drug sensitivity test report of positive blood culture samples can be given within 2 hours.

FastCheck greatly shortens the time-consuming process of targeted drug screening for microbial drug sensitivity, especially for sepsis. Compared with turbidimetric method, a direct counting way based on the Coulter Counter theory has significant advantages both on efficiency and accuracy. It realizes the leap from qualitative detection to quantitative detection, and leads the technological change of microbial drug sensitivity detection, especially the rapid drug sensitivity detection of sepsis.

patented volumetric metrology control technology protects the data integrity of a single drug susceptibility test. It is the first choice for microbial susceptibility testing such as sepsis.